Mesenchymal Stem Progeitors are derived from human embryonic cell line, H9 （WA09）. Cells are ＆amp;gt;80％ CD90, CD105, CD166 and CD73 positive and ＆amp;lt;5％ Oct4 positive. Cells have the capabilties to： Form adherent monolayers – ideal for 96-and 384-well formats for high throughput and high content cell-based assays.To differentiate into a wide variety of mesenchymal subtypes, including osteogenic and chondrogenic lineages （but not adipogenic）– ideal for drug discovery for a wide variety of biological targets and basic research in bone, cartilage, metabolic and immunological diseases.Passage up to 10X.Note： Please include a 30 USD dry ice charge when ordering. Pricing is for US and Canada only.Specifications： Cell Type： mesenchymal progenitor cells Species： human Source： derived from human embryonic cell line, H9 （WA09） Morphology： fibroblasticQuantity： ＆amp;gt;1x10^6 cells per vial （viable post-thaw） Shipping method： dry iceStorage： liquid nitrogenGrowth Properties： adherent, proliferative Medium： αMEM Medium supplemented with 10％ FBS, Pen/Strep and L-glutamine Phenotyping： Cells are ＆amp;gt;80％ CD90, CD105, CD166 and CD73 positive and ＆amp;lt;5％ Oct4 positive. DNA fingerprint： Results are consistent with the presence of a single cell line with no evidence of culture cross contamination. Pathogen testing： This lot was derived from the H9 hESC line that has been tested for Hepatitis B, Hepatitis C, HIV-1, HIV-2, HTLV-I/II, HSV1, HSV2, EBV, and CMV. The H9 cell line has been tested and shown to be negative （performed by GIVF Laboratories）. Mesenchymal cells are also tested for sterility and mycoplasma contamination.
